GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Shiller PE Ratio

Marksans Pharma (NSE:MARKSANS) Shiller PE Ratio : 36.77 (As of Jun. 01, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Shiller PE Ratio?

As of today (2024-06-01), Marksans Pharma's current share price is ₹148.55. Marksans Pharma's E10 for the quarter that ended in Mar. 2024 was ₹4.04. Marksans Pharma's Shiller PE Ratio for today is 36.77.

The historical rank and industry rank for Marksans Pharma's Shiller PE Ratio or its related term are showing as below:

NSE:MARKSANS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.64   Med: 19.96   Max: 43.86
Current: 36.77

During the past years, Marksans Pharma's highest Shiller PE Ratio was 43.86. The lowest was 13.64. And the median was 19.96.

NSE:MARKSANS's Shiller PE Ratio is ranked worse than
75.61% of 537 companies
in the Drug Manufacturers industry
Industry Median: 24.1 vs NSE:MARKSANS: 36.77

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Marksans Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹1.730. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹4.04 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Marksans Pharma Shiller PE Ratio Historical Data

The historical data trend for Marksans Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Shiller PE Ratio Chart

Marksans Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 15.73 20.05 37.60

Marksans Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.05 24.91 29.05 41.19 37.60

Competitive Comparison of Marksans Pharma's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Marksans Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Shiller PE Ratio falls into.



Marksans Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Marksans Pharma's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=148.55/4.04
=36.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marksans Pharma's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Marksans Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.73/153.0345*153.0345
=1.730

Current CPI (Mar. 2024) = 153.0345.

Marksans Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.660 94.103 1.073
201409 0.810 96.780 1.281
201412 0.720 96.780 1.139
201503 0.480 97.163 0.756
201506 0.770 99.841 1.180
201509 0.850 101.753 1.278
201512 0.440 102.901 0.654
201603 -0.140 102.518 -0.209
201606 0.110 105.961 0.159
201609 0.020 105.961 0.029
201612 0.240 105.196 0.349
201703 -0.150 105.196 -0.218
201706 0.330 107.109 0.471
201709 0.230 109.021 0.323
201712 0.410 109.404 0.574
201803 -0.170 109.786 -0.237
201806 0.580 111.317 0.797
201809 0.480 115.142 0.638
201812 0.600 115.142 0.797
201903 0.210 118.202 0.272
201906 0.520 120.880 0.658
201909 0.630 123.175 0.783
201912 0.710 126.235 0.861
202003 1.090 124.705 1.338
202006 1.200 127.000 1.446
202009 1.210 130.118 1.423
202012 1.420 130.889 1.660
202103 1.998 131.771 2.320
202106 1.510 134.084 1.723
202109 1.110 135.847 1.250
202112 1.200 138.161 1.329
202203 0.690 138.822 0.761
202206 1.460 142.347 1.570
202209 1.520 144.661 1.608
202212 1.560 145.763 1.638
202303 1.870 146.865 1.949
202306 1.520 150.280 1.548
202309 1.840 151.492 1.859
202312 1.840 152.924 1.841
202403 1.730 153.035 1.730

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Marksans Pharma  (NSE:MARKSANS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Marksans Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines